Although infections of mouse cells by a murine leukemia virus (MuLV) are usually thought to result in a virus-producing infected cell, there are reports of nonproductive cells that produce viral antigens and were therefore infected (42, 47) . Such a state is also seen in cultured normal cells from certain mouse strains and reflects expression of endogenous viral genomes; in fact, most mouse cells express some viral antigen but make no virus (6, 32, 38, 51) . __-A few years ago we noted that a culture of cells infected with Moloney MuLV (M-MuLV) was producing decreasing yields of virus with continuous passage. We have recovered from that culture a nonproducer cell line that expresses viral glycoprotein but little of the other viral proteins. Cells productively infected with M-MuLV make gene products from the three known genetic regions of the M-MuLV genome: gag (the internal virion proteins), pol (the reverse transcriptase), and env (the glycoprotein). The nonproducer cell line isolated in these studies is infected with a deleted M-MuLV genome that makes no normal gag or pol products but has an apparently normal env gene product and a normal env mRNA.
MATERIALS AND METHODS
Cells and leukemia viruses. Most of the cells and viruses have been described previously. JLS-V11 cells (58) were provided by Electronucleonics Inc., Bethesda, Md., 18 passages after their infection with MMuLV. JLS-V9 (V9) cells (58) were obtained from Kenneth Manly (Roswell Park Memorial Institute). NIH/3T3 cells (26) were a gift of S. A. Aaronson (National Institutes of Health). BALB/3T3 cells clone A31 (1) were obtained from R. Pollack, and the 8c subclone 81 cat cells, a sarcoma-positive leukemianegative (S+L-) cat cell line transformed by Moloney murine sarcoma virus (17) , was kindly provided by P.
Fischinger. NIH/3T3 cells producing M-MuLV clone supernatants were done as described elsewhere (20) .
Infective center assays were carried out by a modification of a published procedure (26) . Sensitive BALB/3T3 cells were plated at 105 cells per 6-cm dish. The next day, cells to be tested were trypsinized for 10 min with 0.5% trypsin at room temperature, diluted into medium, and then plated onto the indicator cells at various densities. After 3 days the cultures were UV irradiated and overlaid with XC cells. The plating efficiency of the cells was determined separately. JLS-V9 and JLS-V11 routinely gave plating efficiencies of 60 to 80%.
Antisera. Fluorescein-conjugated antibody to Tween-ether-disrupted M-MuLV made in goats and rhodamine counter stain were obtained through the Virus Cancer Program. Anti-Friend MuLV gp7O serum made in rabbits was kindly provided by D. Bolognesi. Goat anti-rabbit immunoglobulin and normal rabbit serum were purchased from Meloy Laboratories. AntiMuLV p30 serum made in rabbits was kindly provided by David Livingston. Anti-M-MuLV p30 and gp69/70 antisera made in rabbits were prepared in this laboratory (39) .
Radioimmunoassays. The cell extracts were prepared as follows. Subconfluent plates of cells (15 cm) were harvested with phosphate-buffered saline (PBS) (pH 7.4)-2 mM EDTA and then washed three times with PBS. Cells were stored as 20% cell packs at -70°C. The cell packs were disrupted in 1% Triton X-100 and 0.5% sodium deoxycholate, and the nuclei were collected by centrifugation at 2,000 rpm for 4 min. The supernatant was then extracted twice with ether, and the aqueous phase was dialyzed with 0.05 M Tris-hydrochloride (pH 7.8) and used for the radioimmunoassay. The radioimmunoprecipitation assays for the p30 protein were performed as described by Parks et al. (38) . Protein determinations were done by the Lowry (31) method with bovine serum albumin as a standard. The first incubation was carried out in 450 td of 0.1 M NaPO4, (pH 7.5), 1% normal rabbit serum, 0.01% Triton X-100, 0.01 M EDTA, competing antigen and rabbit anti-M-MuLV p30 for 1 h at 37°C, and then 50 pl of '2I-p30 (10,000 cpm) in 0.1 M NaPO4 (pH 7.5), 0.01% Triton X-100, 0.01 M EDTA, and 1% normal rabbit serum was added and incubated for another hour at 37°C. Finally, 30 ul of goat anti-rabbit immunoglobin serum was added, and the mixture was incubated for 1 h at 37°C. The precipitate was collected by centrifugation for 10 min at 3,000 cpm. The supematant was decanted, and the pellet was washed with 0.5 ml of 1-mg/ml bovine serum albumin-0.1% Nonidet P-40 in PBS. The precipitate was again collected by centrifugation. This washing procedure was repeated three times. The tubes were then counted in a gamma-ray counter.
Immunofluorescence. Cytoplasmic staining was carried out as described previously (20) . 50 ,uCi/ml) in Dulbecco-modified Eagle medium containing 1/50 the normal methionine concentration and 10% dialyzed heat-inactivated fetal calf serum. The cells were lysed with 0.01 M phosphate (pH 7.2), 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and 0.15 M NaCl. The lysates were scraped from the plates and clarified by centrifugation for 10 min at 1,000 x g.
To reduce nonspecific background in the immunoprecipitation, the lysates were precleared by the technique of Witte et al. (56) . Extracts were incubated overnight with 10 pl of normal rabbit serum at 4°C and then for 1 h at 4°C with 100 pl of 10% (wt/vol) Formalin-fixed Staphylococcus aureus as previously described (28) . The components bound to S. aureus were collected by centrifugation for 30 min at 35 ,000 rpm in a Beckman ultracentrifuge.
The supernatants were then immunoprecipitated by overnight incubation at 4°C with the appropriate antiserum followed by 1 h of incubation with S. aureus (as above). The precipitates were washed three times with lysis buffer, resuspended in 50 ,ll of 50 mM Tris (pH 6.8)-1% 2-mercaptoethanol-1% SDS-10% glycerol-bromophenol blue, boiled for 5 min, and analyzed on 5 to 20% gradient slab gels (29) . The gels were stained and dried, and the labeled bands were visualized by fluorography and autoradiography at -70°C (9) .
Extraction and analysis of cytoplasmic RNA. Cytoplasmic RNA from producer and nonproducer cells was prepared as described previously (14) and by the urea-SDS method (19) as described by Sharp et al. (46) . Polyadenylic acid-containing RNA was prepared by affinity chromatography on oligodeoxythymidylic acid-cellulose (T3, Collaborative Research) (3) . Cytoplasmic RNAs were analyzed in 15 to 30% sucrose gradients containing 0.1% SDS as described previously (14) . Purified polyribosomes were prepared as described previously by sedimenting polyribosomes from cytoplasmic extracts through 1 and 2 M sucrose (15, 18 (16) in vitro in the endogenous RNAdependent DNA polymerase reaction, as described previously (13 Hybridization of cytoplasmic RNAs with M-MuLV cDNA to measure extent and concentration of virusspecific RNA sequences was as previously described (13) . Briefly, the RNA samples were combined with 3H-labeled M-MuLV cDNA (500 to 1,000 cpm) and incubated for the times indicated. Annealing conditions were 0.3 M NETES (0.3 M NaCl, 0.01 M TES, pH 7.5, 1 mM EDTA)-0.1% SDS at 66°C, and the total reaction volume was 5 to 7 p1. After annealing, the samples were expelled into 50 pl of S1 nuclease reagent (40 U of S1 nuclease per ml, 0.25 M K acetate [pH 4.5], 20 ,ug of denatured calf thymus DNA per ml, 0.01 M ZnSO4), and the unhybridized cDNA was digested for 30 to 60 min at 45°C. The S1-resistant matekial was precipitated with trichloroacetic acid, and radioactivity in precipitated material was measured by filtration (Millipore Corp.) and liquid scintillation counting.
Hybridization across sucrose gradients was performed as described (13) . Briefly, samples of sucrose gradient fractions were adjusted to annealing conditions and M-MuLV cDNA (500 to 1,000 cpm) was added to each sample. After incubation of all of the samples for the same length of time, the hybridized cDNA was measured and converted to relative virusspecific RNA concentration as described before (13) .
Transfer of RNA from agarose gels to diazobenzyloxymethyl paper. The aminobenzyloxymethyl paper was prepared from 1-[(m-nitrobenzyloxy)methyl]pyridium chloride and stored in a desiccator at 5°C. Immediately before the transfer was started the paper was diazotized at 4°C. The methylmercuric hydroxide agarose gel was quenched with 0.5 M NH4Ac and stained with 10 ,ug of ethidium bromide per ml. The gel was then placed into 200 ml of 50 mM NaOH-5 mM 2-mercaptoethanol and rocked gently for 30 min at room temperature. The gel was then treated with 200 ml of 200 mM potassium phosphate (pH 6.5) containing 7 mM iodoacetic acid for 10 min at room temperature and then twice with 200 ml of 25 mM potassium phosphate (pH 6.5) for 5 min at room temperature. After treatment as above the procedure for transfer was essentially the same as the one described by Southern (48) except that 25 mM potassium phosphate (pH 6.5) was used. Transfer was allowed to proceed overnight. After the transfer the paper was washed twice in 200 ml of water, dried in air, and stored at 5°C until used for hybridization. For hybridization to the RNA bound to the paper the procedure was the same as described by Alwine et al. (2) . The paper was pretreated overnight at 42°C with hybridization buffer (50% formamide, 0.75 M sodium chloride, 75 mM sodium citrate) containing 0.02% (wt/vol) each of bovine serum albumin, Ficoll, and polyvinylpyrolidone; 1.5 mg of denatured calf thymus DNA per ml, and 1% (wt/vol) glycine. Hybridization was then performed in the same mixture without the glycine and the probe (200,000 cpm/2 ml) for 36 h at 42°C. The paper was then washed with six to eight changes of hybridization buffer at 37°C each for 30 min with rocking and then with three changes of 50 mM sodium chloride-3 mM sodium citrate at 4°C. The paper was blotted to remove excess solution, wrapped in Saran Wrap, and visualized by autoradiography. RESULTS JLS-V9 is a cell line that was derived from BALB/c bone marrow; on infection with MMuLV these cells were designated JLS-V1l (58). JLS-Vll cells were received in our laboratory at the 18th transfer, and by the 40th transfer virus production had dropped markedly as measured by the amount of reverse transcriptase activity, or particles banding at 1.16 g/cm3, in the medium. We were interested to determine whether this alteration in virus production was due to a general decrease in virus production in all cells, or whether it was the result of selection of virusnegative cells present in the original JLS-Vll culture. An infective center assay at passage 121 revealed that only 0.4% of the cells were producing M-MuLV, but the virus-positive cells produced normal quantities of virus. Therefore, it appeared that we were dealing initially with a heterogenous population of cells, and thus we cloned early and late passage JLS-Vll cells.
In a clone isolated from passage 21 of JLSVll cells (hereafter referred to as "Vll" cells), all of the cells were producing virus as measured by an infective center assay. After culture for more than 1 year (more than 50 transfers), they remained stable producers. From the late transfer JLS-Vll cells (transfer 121), 15 clones were isolated, all of which were negative for the production of type C virus both by release of plaque-VOL. 29, 1979 forming virus measured by XC cell assay and by particle-associated DNA Pr180909-P°', the precursor of p85 (reverse transcriptase) (25, 27, 36) ; and (iii) PrSOenv, the precursor of the envelope proteins, mainly the glycoprotein gp7O (12, 34, 57) . In characterizing Vll-NP cells, we first determined whether any of the viral proteins were expressed.
The quantity of p30, the major structural virion protein, and a cleavage product of Pr65sag was measured by radioimmunoassay ( Fig. 1) . V11-NP cells had no more p30 antigenic material than uninfected V9 cells (-10 ng/mg), whereas Vll cells producing M-MuLV and V9 cells induced with bromodeoxyuridine to produce endogenous MuLV (8) had high levels of p30 antigen (500 to 1,500 ng/mg). In this radioimmunoassay, iodinated Rauscher MuLV p30 and homologous antibody made against Rauscher p30 protein were used. To further investigate viral protein synthesis, polyacrylamide gel electrophoresis of specific immunoprecipitates was used (Fig. 2) 1) , and V9 cells (slots m to p) were analyzed with a variety of antisera. V9 cells had no specific proteins. Vll cells showed the array of proteins previously characterized in other systems: Pr1809)a9POI precipitated with anti-reverse transcriptase (slot a) and anti-p30 (slot c) and products from about p145 to p85 precipitated only with anti-reverse transcriptase; Pr65sas, p30, and some intermediates precipitated with anti-p30 and anti-whole virus serum (slot e); Pr80env precipitated with anti-gp7O (slot b) and anti-whole virus serum. Some Pr65i'9 precipitated with the anti-reverse transcriptase serum because a known contaminating activity in the serum reacts with the p15 component of Pr65as (56) . Normal rabbit serum precipitated no proteins (slot f), and p30 competed out all precipitation with anti-p30 (slot d).
V11-NP cells had no detectable Pri8O9 9P" or Pr659"9 with the same sera (slots g and i) but did have Pr80env (slot h). The anti-whole virus serum (slot h) precipitated a diffuse band at 70,000 molecular weight that is presumed to be the cleaved form of glycoprotein, gp7O. Why the anti-gp7O detected so little of this polypeptide is not known, but this antiserum has previously been shown to be much more avid for Pr80eMG than for gp7O (47) .
A minor component in V11-NP cells, P45, was precipitated with anti-p30 (slot i) and anti-whole virus serum (slot k). The reactivity with antip30 was competed out with p30 (slot j). A P45 polypeptide was also evident in Vll cells ex- tracts (slots c and e). Its concentration was very much less than that of the other p30-related polypeptides in Vll cells, and we are uncertain whether it derives from the M-MuLV genome or from an endogenous or contaminating virus.
From the immunoprecipitation data, Vll-NP cells appear to contain the glycoprotein precursor as well as finished gp7O. Immunofluorescent staining of live and acetone-fixed cells with monospecific anti-gp7O antiserum showed that the glycoprotein was found both in the cytoplasm of fixed cells and on the cell membrane of live cells (unpublished data).
To investigate whether both gp70 and Pr80env were localized on the outer cell membrane, Vll-NP cells were radioiodinated with lactoperoxidase as catalyst. Immunoprecipitation and polyacrylamide gel electrophoresis showed that only labeled gp70 was precipitated with anti-gp70 (Fig. 3, lane a) (Table 1) . To examine whether this strong resistance to superinfection occurred at the cell surface, the pseudotype virus, vesicular stomatitis virus (VSV)(M-MuLV), was produced by infecting M-MuLV-producing cells with heat-labile VSV tl-17 (7, 59 with VSV tl-17 in parallel, and the two VSV stocks were then heated at 45°C to eliminate the pure VSV in the populations. To detect pseudotypes, the stocks were assayed on V9 cells or Vll-NP cells (Table 2) . Although the stock grown on the M-MuLV-infected cells had 103 PFU of pseudotype VSV per ml that appeared on V9 cells but not Vll-NP cells, no such pseudotypes were evident in the VSV preparation made on V11-NP cells. The gp7O on the surface of Vll-NP cells thus appears incapable of participating in pseudotype virion synthesis. Expression of M-MuLV-specific RNA in producer and nonproducer cells. The MMuLV-specific RNA in Vll-NP cells was examined to determine whether the lack of viral proteins in the nonproducer cells was due to an alteration in the expression of virus-specific RNA. Cytoplasmic RNA extracted from producer and nonproducer cells was annealed with M-MuLV cDNA in conditions of virus-specific RNA excess (13) . At saturation, RNA from the Vll-NP cells could anneal M-MuLV cDNA to the same (maximal) extent as RNA from the producer cells (Fig. 5) , indicating that essentially all virus-specific RNA sequences that could be recognized by the M-MuLV cDNA probe were present in the nonproducer cells. In annealing experiments performed in this manner, the virus-specific RNA concentration is inversely proportional to the product of RNA concentration and annealing time that gives half-maximal annealing (the Crtl/2 value) (13) (4.02 x 1o-2 mol-s/liter at standard annealing conditions [15] ) indicated that 0.03% of the cytoplasmic RNA from Vll-NP cells and 0.10% of the producer cell cytoplasmic RNA was virus specific. The lack of virus production in the nonproducer cells, therefore, did not result from marked alteration in the expression of virusspecific RNA because no change in extent of MMuLV-specific sequences present was detected and the concentration of these sequences was only threefold lower than for producer cells.
Uninfected BALB/c mouse cells contain RNA sequences that can anneal with M-MuLV cDN to a limited extent (6, 8, 14, It; at least some of tnese seuences may represent endogenous Ctype irsesTo ensure that t Fig. 5 were analyzing transcription of M-MuLV cDNA and not uninfected cell sequences, producer and nonproducer cell RNAs were annealed with M-MuLV cDNA that had been depleted of sequences that anneal with uninfected BALB/c cell DNA (a kind gift of Rudolf Jaenisch). V11-NP and Vll cell RNA annealed to equal extents to the selected cDNA probe (Fig.   6 ). The CrtI/2 values indicated that with these RNA preparations, the nonproducer cell cytoplasmic RNA contained approximately onefourth as much virus-specific RNA as producer cells (0.06 versus 0.26%).
Intracellular virus-specific RNA in cells producing MuLV consists of 38S and 21S virusspecific RNA (11, 13, 33, 43, 54) . To examine whether the same virus-specific RNA species were present in the nonproducer cells, cytoplas- mic RNA extracted from Vll-NP was separated by electrophoresis through denaturing methylmercuric hydroxide agarose gels. The RNA was transferred from the agarose gel to diazobenzyloxymethyl paper, an affinity paper for nucleic acids described by Alwine et al. (2) . The virusspecific RNAs covalently linked to the paper were then detected by hybridization with Plabeled M-MuLV cDNA. The largest viral RNA in the Vll-NP cells (Fig. 7, lane b) was 1,000 nucleotides shorter than that of wild-type MMuLV RNA (Fig. 7, lane a) ; the subgenomic 21S RNA was present in both the M-MuLV-producing cells (Fig. 7, lane c) and the Vll-NP and was apparently the same size in the two cell lines. Vll producer cells contained the regular genomic 38S RNA, subgenomic 21S RNA, and an RNA that comigrated with the larger virus-specific RNA of the Vii-NP cells (Fig. 7, lane c) . Uninfected cells showed no RNA bands by this procedure (Fig. 7, lane d) .
The Vll-NP cells therefore appear to contain a genome having a 1,000-nucleotide deletion. The deletion, though, does not affect the size of the 21S subgenomic RNA, implying that the deletion occurs outside of the regions covered by this RNA. The inability to detect the deletion by liquid hybridization experiments (Fig. 5 and  6 ) is probably a consequence of its representing only 11% of the 9,000-nucleotide genome. The Vll producer cells contained both full-length 38S RNA as well as a species with most likely the same deletion as the one found in the Vll-NP cells. Virus produced by the Vll cells also contains full-length 38S RNA and the deleted molecule (P. Besmer, unpublished data).
To determine whether the deleted genomic RNA as well as the 21S subgenomic RNA was contained in polyribosomes, the polyribosome fraction of the Vii and V11-NP cells was treated with or without EDTA and analyzed by sedimentation through sucrose gradients. Virus-specific RNA in the "released messenger region" of the sucrose gradients (50 to 200S) was further analyzed by sedimentation through sucrose-SDS gradients, and virus-specific RNA appearing in this region after EDTA disruption of polyribosomes was scored as functional mRNA. (15) . By this criterion polyribosomes from the Vll-NP and the Vii cells contained both genome size 35 to 38S and subgenomic 21S mRNA's (Fig. 8) . The deleted genome RNA from the Vll-NP cells is therefore found on polyribosomes as well as the subgenomic 21S RNA.
Can the virus genome in the V11-NP cells be rescued? Previously we have shown that uninfected V9 cells can be induced to produce the BALB/c endogenous xenotropic (MuLVx) and ecotropic (MuLVE) virus upon treatment with halogenated pyrimidines (8) . The N-tropic MuLV does not form XC cell plaques when assayed in an XC assay with NIH/3T3 cells as indicators (50) . Vll-NP cells were treated with bromodeoxyuridine to determine whether the compound could induce the endogenous V9 viruses, which might then rescue or complement the M-MuLV contained in the Vii-NP cells. The virus yield 2 days after removal of the halogenated pyrimidine was determined (Table  3 ). V9 cells upon induction produced 3 24 ,000 rpm and 25°C, the gradients were fractionated, and 100-pl portions of each fraction were concentrated by ethanol precipitation into 50 IlI of 0.3 M NETES-0.1% SDS buffer. 3H-labeled M-MuLV cDNA (550 cpm) was added to each concentrated fraction and annealing was performed at 66°C for 18 h. After annealing, the samples were digested with Sl nuclease, and the amount ofSl-resistant radioactivity was determined. The relative amount of virus-specific RNA present in each fraction was calculated from the percentage of cDNA hybridized as before (a relative virus-specific RNA concentration of corresponds to 50% cDNA probe annealed) (13) . The data from the two sucrose gradients are superimposed, and the locations of the 28S and 18S rRNA's (determined by monitoring the sucrose gradient for absorbance at 260 nm during fractionation) are also indicated. Symbols: 0, data from the EDTA treated polyribosomes; 0, data from the control polyribosomes. (54) , appears to be unchanged in structure and function by the deletion. By contrast, no Pr659 '9 or Pr1809'"" is evident in the cells, implying that the deletion has interferred with their expression. RNA indistinguishable from vRNA is known to be the mRNA for the gag-pol products (27, 33, 54 (56) . In both Vl1-NP and Abelson MuLV-infected cells, the product is immunoprecipitated by anti-p30 antiserum but does not register in radioimmunoassays (37) . Thus, the deletion mutant described here either could be the parent of Abelson MuLV or could represent a site at which deletions or substitutions frequently occur. The virus in Vll-NP cells might even have a partially substituted genome.
An implication from this analysis is that the splicing event that makes the 21S mRNA can occur even though the intervening region has been partly deleted. This conclusion is subject, however, to the reservation that different integrated viral genomes may give rise to the vRNA and to 21S mRNA in Vll-NP cells.
Lack of VSV pseudotype production by Vll-NP cells. Although Vll-NP cells have gp7O on their surface, numerous attempts to produce VSV psuedotypes in these cells have failed ( Table 2 ). This result supports an earlier conjecture (55) that to have a glycoprotein incorporated into the envelope of a virus requires both the glycoprotein and a submembrane protein. The lack of the submembrane Pr65Vg in V11-NP cells presumably prevents gp7O from participating in pseudotype formation.
Mutability ofthe M-MuLV genome. In previous work (20, 35, 41, 42, 47) , we and others have characterized five nonconditional mutant classes of MuLV's that are phenotypically different from the deletion in V11-NP (see reference 47). These other mutants arose from carefully cloned MuLV's in one passage, implying a very high rate of spontaneous mutations during MuLV passage. At least one of the five classes represented a deletion mutant. That deletion (M23) abolished both pol and env function but leftgag function intact (47) . The ability to derive cell lines with a range of M-MuLV mutants should facilitate analysis of the roles of the various gene products in the life of the virus. The high rate of generation of mutants, however, must be considered in any explanations of the behavior retrovirus-infected cells.
